Patent details

EP1638574 Title: NEW PHARMACEUTICAL USES OF STAUROSPORINE DERIVATIVES

Basic Information

Publication number:
EP1638574
PCT Application Number:
PCT/EP/2004/006562
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP047400163
PCT Publication Number:
WO/2004/112794
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEW PHARMACEUTICAL USES OF STAUROSPORINE DERIVATIVES
French Title of Invention:
NOUVELLE UTILISATION DE DERIVES DE STAUROSPORINE
German Title of Invention:
NEUE PHARMAZEUTISCHE VERWENDUNGEN VON STAUROSPORIN-DERIVATEN
SPC Number:
LUC00055

Dates

Filing date:
17/06/2004
Grant date:
14/04/2010
EP Publication Date:
14/04/2010
PCT Publication Date:
29/12/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/03/2006
EP B1 Publication Date:
14/04/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2004
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:
COUTRE Steven
Address:
United States (US)

Priority

Priority Number:
479575 P
Priority Date:
18/06/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/553;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
15/06/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages